Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (2215)

« Back to Publications

CMV serostatus is associated with improved survival and delayed toxicity onset following anti-PD-1 checkpoint blockade

Milotay G. et al, (2025), Nature Medicine

Author Correction: Immunogenic recombinant Mayaro virus-like particles present natively assembled glycoprotein.

Kim YC. et al, (2025), NPJ Vaccines, 10

Re-imagining combination vaccines for travel medicine

McGuinness SL. et al, (2025), Journal of Travel Medicine

The validity of test-negative design for assessment of typhoid conjugate vaccine protection: comparison of estimates by different study designs using data from a cluster-randomised controlled trial.

Feng S. et al, (2025), Lancet Glob Health

A systems biology approach to define SARS-CoV-2 correlates of protection.

Brady C. et al, (2025), NPJ Vaccines, 10

Plasmodium falciparum Subtilisin-Like Domain Containing Protein ((PfSDP) PF3D7_1105800), a Cross-Stage Antigen, Elicits Short-Lived Antibody Response Following Natural Infection with Plasmodium falciparum

Kengne-Ouafo JA. et al, (2025)

Confronting the shortcomings of covid-19 vaccination will help us in future pandemics.

Vanderslott S., (2025), BMJ, 388

The effect of pertussis vaccination in pregnancy on the immunogenicity of acellular or whole-cell pertussis vaccination in Gambian infants (GaPS): a single-centre, randomised, controlled, double-blind, phase 4 trial.

Saso A. et al, (2025), Lancet Infect Dis

Absolute quantification of rare gene targets in limited samples using crude lysate and ddPCR

Kaur C. et al, (2025), Scientific Reports, 15

Complement-mediated enhancement of SARS-CoV-2 antibody neutralisation potency in vaccinated individuals.

Mellors J. et al, (2025), Nat Commun, 16

Epidemiology of Group B Streptococcus: Maternal Colonization and Infant Disease in Kampala, Uganda

Kyohere M. et al, (2025), Open Forum Infectious Diseases

Acceptability of the gonorrhoea human challenge model to accelerate vaccine development in UK men.

Firth C. et al, (2025), Vaccine, 54

A 5-transcript signature for discriminating viral and bacterial etiology in pediatric pneumonia.

Viz-Lasheras S. et al, (2025), iScience, 28

Multi-antigen serology and a diagnostic algorithm for the detection of arbovirus infections as novel tools for arbovirus preparedness in southeast Europe (MERMAIDS-ARBO): a prospective observational study.

Kasbergen LMR. et al, (2025), Lancet Infect Dis

Prevalence, clinical management, and outcomes of adults hospitalised with endemic arbovirus illness in southeast Europe (MERMAIDS-ARBO): a prospective observational study.

Sigfrid L. et al, (2025), Lancet Infect Dis

Safety and immunogenicity of a bivalent Ebola virus and Sudan virus ChAdOx1 vectored vaccine in adults in the UK: an open-label, non-randomised, first-in-human, phase 1 clinical trial.

Jenkin D. et al, (2025), Lancet Microbe

Pneumococcal Carriage and Disease in Adults in England, 2011-2019: The Importance of Adults as a Reservoir for Pneumococcus in Communities.

El Safadi D. et al, (2025), J Infect Dis, 231, e17 - e27

Relation Between the Dantu Blood Group Variant and Bacteremia in Kenyan Children: A Population-Based Case-Control Study.

Kariuki SN. et al, (2025), J Infect Dis, 231, e10 - e16

A novel blood-free analytical framework for the quantification of neuroinflammatory load from TSPO PET Imaging.

Maccioni L. et al, (2025), Res Sq

Artificial intelligence for modelling infectious disease epidemics.

Kraemer MUG. et al, (2025), Nature, 638, 623 - 635

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?